These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2739882

  • 1. A behavioural pharmacological study on intracerebroventricularly administered CCK-8 related peptides in mice.
    Hagino Y, Moroji T, Iizuka R.
    Neuropeptides; 1989; 13(2):107-13. PubMed ID: 2739882
    [Abstract] [Full Text] [Related]

  • 2. A behavioral pharmacological study on CCK-8 related peptides in mice.
    Moroji T, Hagino Y.
    Neuropeptides; 1986 Oct; 8(3):273-86. PubMed ID: 3785587
    [Abstract] [Full Text] [Related]

  • 3. Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin.
    Zetler G.
    Eur J Pharmacol; 1983 Oct 28; 94(3-4):261-70. PubMed ID: 6140174
    [Abstract] [Full Text] [Related]

  • 4. Centrally administered CCK-8 suppresses activity in mice by a "peripheral-type" CCK receptor.
    Britton DR, Yahiro L, Cullen MJ, Kerwin JF, Kopecka H, Nadzan AM.
    Pharmacol Biochem Behav; 1989 Dec 28; 34(4):779-83. PubMed ID: 2623030
    [Abstract] [Full Text] [Related]

  • 5. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.
    Van Ree JM, Gaffori O, De Wied D.
    Eur J Pharmacol; 1983 Sep 16; 93(1-2):63-78. PubMed ID: 6138272
    [Abstract] [Full Text] [Related]

  • 6. L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity.
    Soar J, Hewson G, Leighton GE, Hill RG, Hughes J.
    Pharmacol Biochem Behav; 1989 Jul 16; 33(3):637-40. PubMed ID: 2587606
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clonidine and yohimbine separate the sedation and the ptosis caused by cholecystokinin octapeptide and ceruletide.
    Zetler G.
    Eur J Pharmacol; 1984 Jul 13; 102(2):333-40. PubMed ID: 6090162
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse.
    Suh HW, Kim YH, Choi YS, Song DK.
    Peptides; 1995 Jul 13; 16(7):1229-34. PubMed ID: 8545243
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action.
    Schick RR, Yaksh TL, Go VL.
    Regul Pept; 1986 Jul 13; 14(4):277-91. PubMed ID: 3749526
    [Abstract] [Full Text] [Related]

  • 15. Antistereotypic effects of cholecystokinin octapeptide (CCK-8), ceruletide and related peptides on apomorphine-induced gnawing in sensitized mice.
    Zetler G.
    Neuropharmacology; 1985 Mar 13; 24(3):251-9. PubMed ID: 2859544
    [Abstract] [Full Text] [Related]

  • 16. Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine. A comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and clonazepam.
    Zetler G.
    Neuropharmacology; 1983 Jun 13; 22(6):757-66. PubMed ID: 6310434
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Altered responding to cholecystokinins and dopaminergic agonists following 6-hydroxydopamine treatment in rats.
    Hsiao S, Katsuura G, Itoh S.
    Behav Neurosci; 1985 Oct 13; 99(5):853-60. PubMed ID: 3939625
    [Abstract] [Full Text] [Related]

  • 19. Bilateral subdiaphragmatic vagotomy does not prevent the behavioral effects of systematically administered ceruletide in mice.
    Moroji T, Hagino Y.
    Neuropeptides; 1987 Apr 13; 9(3):217-24. PubMed ID: 3601011
    [Abstract] [Full Text] [Related]

  • 20. Behavioral effect of cholecystokinin octapeptide in vagotomized rats.
    Itoh S, Katsuura G.
    Can J Physiol Pharmacol; 1986 Jun 13; 64(6):745-7. PubMed ID: 3756626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.